CoChat

Lipid Metabolism During Early Stages of Wallerian Degeneration in the Rat Sciatic Nerve

White, Frances V, Toews, Arrel D., Goodrum, Jeffry F., Novicki, Deborah L., Bouldin, Thomas W., Morell, Pierre · 1989 · Journal of Neurochemistry
Cited by 56

The DOI matches its Crossref record.

Abstract

We examined changes in biosynthetic capacity of sciatic nerve during the early stages of Wallerian degeneration, utilizing a model that permits exclusion of nonresident cells from degenerating nerve. Sciatic nerve segments were placed in either 5‐μm pore (allowing infiltration of nonresident cells) or 0.22‐μm pore (excluding nonresident cells) Millipore diffusion chambers and then implanted in the peritoneal cavity of the same 32‐34‐day‐old rat. At times up to 7 days post‐surgery, nerve segments from the chambers, as well as control segments from the contralateral sciatic nerve, were removed and their capacity to incorporate radioactive precursors into lipids and proteins assayed in vitro. In nerve segments from both the 0.22‐ and 5‐μm pore chambers, incorporation of [14 C]acetate into total lipids was decreased relative to control by 50% at 12 h postsurgery and by 85% at day 3. This decreased incorporation of [14 C]acetate reflects primarily decreased de novo synthesis of cholesterol and of fatty acyl residues incorporated into glycerolipids and sphingolipids. There was a preferentially decreased synthesis of cerebrosides and cholesterol (components enriched in myelin) relative to other lipids, while cholesterol esters and free fatty acids (products of membrane degradation) accounted for a greater proportion of the greatly reduced levels of total lipid label. In contrast to [14 C]acetate, incorporation of [3 H]glycerol into lipids was increased up to fourfold, relative to control, 1 day after nerve transection. This increased incorporation of [3 H]glycerol does not reflect de novo synthesis of lipids (which is decreased), but rather removal of toxic fatty acyl residues derived from degradation of myelin lipids; these toxic compounds must be removed by resynthesis into nonmyelin glycerolipids and cholesterol esters. The inhibition of de novo synthesis of myelin lipids in Schwann cells during the early stages of Wallerian degeneration occurs independently of hematogenously‐derived cells. We suggest that Wallerian degeneration rapidly results in some breakdown of myelin, and that the increased free fatty acid levels resulting from degradation of myelin lipids inhibit the de novo synthesis of new myelin lipid.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1989.tb01851.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 56

Metadata

Authors
White, F. V., Toews, A. D., Goodrum, J. F., Novicki, D. L., Bouldin, T. W., & Morell, P.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
1989-04
Volume
52
Issue
4
Pages
1085-1092
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2053663725
Cited by
56
References
0
FWCI
1.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipid Metabolism During Early Stages of Wallerian Degeneration in the Rat Sciatic Nerve. https://app.cochat.ai/papers/10.1111/j.1471-4159.1989.tb01851.x
The paper
White, F. V., Toews, A. D., Goodrum, J. F., Novicki, D. L., Bouldin, T. W., & Morell, P. (1989). Lipid Metabolism During Early Stages of Wallerian Degeneration in the Rat Sciatic Nerve. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1989.tb01851.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.